Cas 628300-66-3,N-[4-chloro-2-(pyridine-4-carbonyl)phenyl]-2,2-dimethylpropionamide

628300-66-3

Post Buying Request

Basic information

Product Name: N-[4-chloro-2-(pyridine-4-carbonyl)phenyl]-2,2-dimethylpropionamide
Synonyms: N-[4-chloro-2-(pyridine-4-carbonyl)phenyl]-2,2-dimethylpropionamide
CAS NO:628300-66-3
Molecular Formula:
Molecular Weight: 316.787
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: N-[4-chloro-2-(pyridine-4-carbonyl)phenyl]-2,2-dimethylpropionamide(CAS DataBase Reference)
NIST Chemistry Reference: N-[4-chloro-2-(pyridine-4-carbonyl)phenyl]-2,2-dimethylpropionamide(628300-66-3)
EPA Substance Registry System: N-[4-chloro-2-(pyridine-4-carbonyl)phenyl]-2,2-dimethylpropionamide(628300-66-3)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 628300-66-3(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

628300-66-3 Suppliers

Recommended suppliers

628300-66-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 628300-66-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,2,8,3,0 and 0 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 628300-66:
(8*6)+(7*2)+(6*8)+(5*3)+(4*0)+(3*0)+(2*6)+(1*6)=143
143 % 10 = 3
So 628300-66-3 is a valid CAS Registry Number.

628300-66-3Upstream product

488828-70-2 N-{4-chloro-2-[(4-pyridyl)hydroxymethyl]phenyl}-2,2-dimethylpropionamide

628300-66-3Downstream Products

105192-42-5 (2-amino-5-chlorophenyl)(pyridin-4-yl)methanone

628300-66-3Relevant academic research and scientific papers

CCR9 INHIBITORS AND METHODS OF USE THEREOF

-

Page 76, (2008/06/13)

The invention relates to compounds represented by Structural Formula I, which can bind to CCR9 receptors and block the binding of a ligand (e.g., TECK) to the receptors. The invention also relates to a method of inhibiting a function of CCR9, and to the use compounds represented by Structural Formula I in research, therapeutic, prophylactic and diagnostic methods.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 628300-66-3